Prognostic Factors in Head and Neck Sarcomas
Author Information
Author(s): R.A. Eeles, C. Fisher, R.P. A'Hern, M. Robinson, P. Rhys-Evans, J.M. Henkl, D. Archer, C.L. Harmer
Primary Institution: The Royal Marsden Hospital
Hypothesis
What are the prognostic factors affecting survival and local recurrence in patients with head and neck sarcomas?
Conclusion
The study found that combined surgery and radiotherapy improves local recurrence-free survival in head and neck sarcomas.
Supporting Evidence
- Only one patient presented with lymph node metastases and only one with distant metastases.
- The overall 5 year survival was 50%.
- Local recurrence occurred as late as 15 years after treatment.
- Patients treated with surgery and radiotherapy had better local control than those treated with radiotherapy alone.
- Favorable independent prognostic factors for local control included tumor site and treatment modality.
Takeaway
Doctors studied 130 patients with rare tumors in the head and neck to see what helps them survive better. They found that surgery plus radiation works best.
Methodology
A retrospective analysis of medical records and histological reviews of patients treated for head and neck sarcomas.
Potential Biases
Potential biases may arise from the exclusion of certain tumor types and the retrospective design.
Limitations
The study is limited by its retrospective nature and the small sample size of head and neck sarcomas.
Participant Demographics
Median age was 36 years, with 53% male participants.
Statistical Information
P-Value
0.003
Confidence Interval
95% CI 39-60
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website